Connecteve successfully closed a 14 billion KRW Series A funding round to advance its AI-driven orthopedic solutions, attracting both existing and new investors.

Target Information

Connecteve, a company specializing in AI-based orthopedic solutions, has recently announced the successful completion of a Series A funding round amounting to 14 billion KRW. This round saw participation from existing investors such as DSC Investment, Stonebridge Ventures, Schmidt, and Reventures, while new investors including BSK Investment, TS Investment, IMM Investment, JB Investment, and Big Move Ventures joined the funding round, bringing the total number of participating venture capital firms to nine.

Connecteve attributes this successful investment to its exceptional technological capabilities and future growth potential, particularly in light of the global economic slowdown and the downturn in the venture investment market. The anticipation surrounding the upcoming launch of AI-powered medical solutions such as CONNEVO KOA, ALI, and Suite is expected to drive innovation in medical practice, offering personalized treatment plans and precise analytical tools for orthopedic surgeons.

Industry Overview in South Korea

The orthopedic medical technology industry in South Korea is experiencing significant growth, spurred by advancements in AI and machine learning applications. The integration of technology into healthcare is reshaping traditional approaches to tr

View Source

Similar Deals

블루포인트 프리딕션

2025

Series A Bio Diagnostics & Testing South Korea
L&S벤처캐피탈 에어스 (AIRS)

2023

Series A Advanced Medical Equipment & Technology (NEC) South Korea
크릿벤처스 펫팜

2023

Series A Veterinary Drugs South Korea
아이디벤처스 큐라미스

2021

Series A Bio Therapeutic Drugs South Korea

DSC인베스트먼트, 스톤브릿지벤처스, 슈미트, 리벤처스, BSK인베스트먼트, TS인베스트먼트, IMM인베스트먼트, JB인베스트먼트, 빅무브벤처스

invested in

코넥티브

in 2023

in a Series A deal

Disclosed details

Transaction Size: $11M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert